Analysis of dystroglycan regulation and functions in mouse mammary epithelial cells and implications for mammary tumorigenesis
- PMID: 16447256
- DOI: 10.1002/jcp.20600
Analysis of dystroglycan regulation and functions in mouse mammary epithelial cells and implications for mammary tumorigenesis
Abstract
Abnormalities in the interactions of cells with the extracellular matrix (ECM) play an important role in the development and progression of many types of cancer and are a hallmark of malignant transformation. The dystroglycan (DG) complex is a transmembrane glycoprotein that forms a continuous link from the ECM to the actin cytoskeleton, providing structural integrity and perhaps transducing signal, in a manner similar to integrins. Deregulated expression of DG has been reported in a variety of human malignancies and related to tumor differentiation and aggressiveness. In breast cancer, reduced DG expression has been associated with patient survival and with loss of differentiation of tumor cells. Limited data are available on DG physiology in epithelial cells. In this study, we used the HC11 spontaneously immortalized murine mammary epithelial cells to study DG function(s) and regulation in normal cells. We found that expression of DG protein and mRNA is cell-cycle and cell-density regulated in these cells. Moreover, expression of both DG subunits increased upon lactogenic differentiation of the HC11 cells. The turnover of cell-surface-expressed DG was evaluated in the same cells and half-life of DG subunits was evaluated to be about 12 h. DG-specific small inhibitory RNAs were used to analyze the effects of a reduced expression of DG in these cells. Cells in which DG expression was suppressed were growth inhibited, accumulated in the S-phase of the cell cycle, failed to undergo lactogenic differentiation, and displayed an increase in the percentage of apoptotic cells. Moreover, changes were observed in the expression and/or activity of several molecules involved in cell growth control. These results demonstrate that DG expression is tightly regulated in normal mammary epithelial cells and support the hypothesis that DG is involved in several functions other than structural integrity in these cells. This finding provides new insight into the roles played by DG in epithelial cell physiology and will contribute to our understanding of its involvement in the process of epithelial cell transformation.
Similar articles
-
Insulin-like growth factor binding protein (IGFBP)-5 is upregulated during both differentiation and apoptosis in primary cultures of mouse mammary epithelial cells.J Cell Physiol. 2006 May;207(2):471-9. doi: 10.1002/jcp.20587. J Cell Physiol. 2006. PMID: 16419030
-
Expression of CSF-I and CSF-I receptor by normal lactating mammary epithelial cells.J Soc Gynecol Investig. 1998 Mar-Apr;5(2):94-101. doi: 10.1016/S1071-5576(97)00108-1. J Soc Gynecol Investig. 1998. PMID: 9509388
-
The caM kinase, Pnck, is spatially and temporally regulated during murine mammary gland development and may identify an epithelial cell subtype involved in breast cancer.Cancer Res. 2000 Oct 1;60(19):5571-7. Cancer Res. 2000. PMID: 11034105
-
Apoptosis in normal and neoplastic mammary gland development.Microsc Res Tech. 2001 Jan 15;52(2):171-81. doi: 10.1002/1097-0029(20010115)52:2<171::AID-JEMT1003>3.0.CO;2-T. Microsc Res Tech. 2001. PMID: 11169865 Review.
-
The dystroglycan complex: from biology to cancer.J Cell Physiol. 2005 Nov;205(2):163-9. doi: 10.1002/jcp.20411. J Cell Physiol. 2005. PMID: 15920757 Review.
Cited by
-
Matrix Metalloproteases-Mediated Cleavage on β-Dystroglycan May Play a Key Role in the Blood-Brain Barrier After Intracerebral Hemorrhage in Rats.Med Sci Monit. 2019 Jan 28;25:794-800. doi: 10.12659/MSM.908500. Med Sci Monit. 2019. PMID: 30686819 Free PMC article.
-
Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients.J Exp Clin Cancer Res. 2012 Sep 11;31(1):71. doi: 10.1186/1756-9966-31-71. J Exp Clin Cancer Res. 2012. PMID: 22964035 Free PMC article.
-
Dystroglycan loss disrupts polarity and beta-casein induction in mammary epithelial cells by perturbing laminin anchoring.J Cell Sci. 2006 Oct 1;119(Pt 19):4047-58. doi: 10.1242/jcs.03103. Epub 2006 Sep 12. J Cell Sci. 2006. PMID: 16968749 Free PMC article.
-
Mice lacking dystrophin or alpha sarcoglycan spontaneously develop embryonal rhabdomyosarcoma with cancer-associated p53 mutations and alternatively spliced or mutant Mdm2 transcripts.Am J Pathol. 2010 Jan;176(1):416-34. doi: 10.2353/ajpath.2010.090405. Epub 2009 Dec 17. Am J Pathol. 2010. PMID: 20019182 Free PMC article.
-
Altered expression of natively glycosylated alpha dystroglycan in pediatric solid tumors.Hum Pathol. 2007 Nov;38(11):1657-68. doi: 10.1016/j.humpath.2007.03.025. Epub 2007 Jul 19. Hum Pathol. 2007. PMID: 17640712 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources